$CERT

Certara Inc

  • NASDAQ

PRICE

$22.09 ▲2.936%

Last Close

VOLUME

299,424

DAY RANGE

21.485 - 22.53

52 WEEK

16.18 - 45.48

Join Discuss about CERT with like-minded investors

profile
@dros #droscrew
recently

+Initiations 7/23: $ACRS $AGFY $AHH $AIZ $CALX $CERT $IMV $INDI $INSE $IS $KERN $MP $OGN $PLL $PLUG $THRY $XXII

136 Replies 13 👍 15 🔥

profile
@Pyrognosis #droscrew
recently

That dude was lampooned in bulk yesterday for being an AMC bagholder with a now diminished CFA cert

66 Replies 12 👍 14 🔥

profile
@lucullus #droscrew
recently

not saying it doesnt go lower...just i have no idea about lower prices whereas 316.35 to 315.1 looked an almost cert

74 Replies 14 👍 14 🔥

profile
@lucullus #droscrew
recently

yeah....i think its almost a certainity...sumitomo own a huge percentage of it....THE ONLY PROBLEM FOR THEM IS THAT PFE has just signed a big $4 bill deal with MYOV.....they also got a new PDUFA ON jUNE WHICH IS A DEAD CERT....if they get for $45 it will be a very cheap buy

148 Replies 15 👍 12 🔥

profile
@truublue #droscrew
recently

I wouldn't expect official news on 737 cert on the same day as the FAA flight

47 Replies 10 👍 15 🔥

Key Metrics

Market Cap

3.53 B

Beta

1.67

Avg. Volume

524.40 K

Shares Outstanding

159.84 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the US FDA in the past six years were supported by Certara software or services. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.

Website:

HQ: ,

Related News